39
Participants
Start Date
April 1, 2014
Primary Completion Date
February 23, 2018
Study Completion Date
February 23, 2018
Gonadorelin acetate subcutaneous (SC) 10 μg/pulse as a fixed dose, administered via. OmniPod pump
Gonadorelin acetate SC 15 μg/pulse as a fixed dose, administered via. OmniPod pump
Gonadorelin acetate SC 20 μg/pulse as a fixed dose, administered via. OmniPod pump
Placebo (SC 10, 15, or 20 μg/pulse as a fixed dose, administered via. OmniPod pump)
Fertility Treatment Center, Tempe
Center for Reproductive Health UCSF, San Francisco
University of Colorado School of Medicine, Aurora
Reproductive Associates of Delaware, Newark
Columbia Fertility Associates, Washington D.C.
Women's Medical Research Group, LLC, Clearwater
Center for Reproductive Medicine, Orlando
Georgia Reproductive Specialists, Atlanta
Fertility Centers of Illinois, Chicago
Cypress Medical Research Center, Wichita
Bluegrass Clinical Research Inc., Louisville
Maine Medical Center-REI, Portland
Massachusetts General Hospital, Boston
Wayne State University Physicians Group, Southfield
Weill Cornell Medical College, New York
Carolinas HealthCare System, Charlotte
Lyndhurst Clinical Research, Winston-Salem
Wake Forest University Health Sciences, Winston-Salem
Institute for Reproductive Health, Cincinnati
University of Cincinnati Physicians, Cincinnati
UH Case Medical Center, MacDonald Clinical Trials, Cleveland
Ohio Reproductive Medicine, Columbus
University of Oklahoma Health Sciences Center, Abington IVF & Genetics, L.P., Oklahoma City
Abington Reproductive Medicine, PC, Abington
Main Line Fertility Center, Bryn Mawr
Penn State MS Hershey Medical Center, Penn State College of Medicine, Hershey
University of Pittsburgh, Magee-Womens Hospital, Pittsburgh
Fertility Associates of Memphis PLLC, Memphis
Center for Assisted Reproduction, Bedford
Houston Fertility Institute, Houston
Center of Reproductive Medicine, Webster
Utah Fertility Center, Pleasant Grove
Jones Institute for Reproductive Medicine, Norfolk
Olive Fertility Centre, Vancouver
Ovo, Montreal
Lead Sponsor
Ferring Pharmaceuticals
INDUSTRY